SYNTHESIS OF QUINAZOLINONE DERIVATIVES AND THEIR ANTIMICROBIAL EVALUATION
HTML Full TextSYNTHESIS OF QUINAZOLINONE DERIVATIVES AND THEIR ANTIMICROBIAL EVALUATION
Ompal Singh *1, K.P. Namdeo 3 and V.R. Sindhia 2
Kharvel Subharti College of Pharmacy, Swami Vivekanand Subhari University 1, Meerut 250004, Chhattisgarh, India
N.K.B.R. College of Pharmacy and Research Centre 2, Meerut-245206, Uttar Pradesh, India
SLT Institute of Pharmaceutical Sciences, GGU University 3, Bilaspur, Chhattisgarh, India
ABSTRACT
Some new series of 3-(4-substituted-phenyl)- 2-thioxo-2,3-dihydroquinazolin-4(1H)-one, 3-(4-substituted-phenyl)-2-(methylthio)quinazolin-4(3H)-one and 3-(4-substituted-phenyl)-2-hydrazinylquinazolin-4(3H)-one were synthesized by cyclization of 4-substituted-phenylcarbamodithioate with methyl anthranilate followed by reaction with dimethylsulphate and then prepared compound was refluxed with hydrazinehydrate respectively. The starting material 4-substituted-phenylcarbamodithioate was synthesized from 4-substituted-aniline. The title compounds were investigated for antibacterial and antifungal activity by disc diffusion technique. Compound IIa, IIb and IIIa showed moderate activity against B. subtilis, E. coli and A. niger as compared to standard drug. Compound IIIb and Iva exhibited good activity against A. niger. Compound IIIc and IVc was found to be most active compound against E. coli and moderately active against B. subtilis and A. niger, of the prepared series.
Keywords: |
Quinazolinone, Antibacterial activity, Antifungal activity
INTRODUCTION: The quinazolinone skeleton is a frequently encountered heterocycle in medicinal chemistry literature with applications including analgesic-anti-inflammatory 1, antibacterial 2, antimalarial 3, CNS depressant- anticonvulsant 4, antihistaminic 5, antiviral 6, antitumor 7 and antitubercular 8 activities.
The present work is an effort towards the development and identification of new molecules for antibacterial and anti-fungal activity.
On this basis, we synthesized some 3-(4-substituted-phenyl)-2-thioxo-2, 3-dihydroquinazolin-4(1H)-one, 3-(4-substituted-phenyl)-2-(methylthio)quinazolin-4(3H)-one and 3-(4-substituted-phenyl)-2-hydrazinyl quinazolin-4(3H)-one the title compounds, we aimed to synthesize these compounds by a novel innovative route 9 (Figure 1, Reaction Scheme). The synthesized compounds were tested for their antibacterial and anti-fungal activities.
MATERIALS AND METHODS: Melting points (mp) were taken in open capillaries on Thomas Hoover melting point apparatus and are uncorrected. The IR spectra were recorded in potassium bromide disks on a Perkine Elmer Model-398 spectrometer. The 1H spectra were recorded on a DPX-300 MHz Bruker FT-NMR spectrometer. The chemical shifts were reported as parts per million (ppm) tetramethylsilane (TMS) as an internal standard. Mass spectra were obtained on a JEOL-SX-102 instrument using fast atom bombardment (FAB positive).
FIGURE 1 REACTION SCHEME
The progress of the reaction was monitored on readymade silica gel plates (Merck) using chloroform methanol (9:1) as a solvent system. Iodine was used as a developing agent. All microbial strains used in present study were obtained from Institute of Microbial Technology, Chandigarh (India). Chemicals and reagents were obtained from Aldrich (USA), CDH Delhi and SD Fine Mumbai (India) was used without further purification.
Experimental:
Synthesis of 3-(4-substituted-phenyl)-2-thioxo-2, 3-dihydroquinazolin-4(1H)one (IIa-c): A solution of substituted aniline (0.1 mol) in dimethyl sulphoxide (50 mL) was stirred vigorously. To this was added carbon disulphide (8 mL) and aqueous sodium hydroxide 6 mL (20 mol solution) drop wise during 30 min with stirring. Dimethyl sulphate (0.1 mol) was added gradually keeping the reaction mixture stirring in freezing mixture for 2 h. The reaction mixture was then poured into ice water. The solid (Ia-c) obtained was filtered, washed with water, dried and recrystallized from ethanol. Methyl anthranilate (0.05 mol) and the above prepared compound (Ia-c) (0.05 mol), were dissolved in ethanol (100 mL).
To this anhydrous potassium carbonate (500 mg) was added and refluxed for 21 h. The reaction mixture was cooled in ice and the solid separated was filtered and purified by dissolving in 10% alcoholic sodium hydroxide solution and reprecipitated by treating with dilute hydrochloric acid. The solid obtained of compound (IIa-c) was filtered, washed with water, dried under high vacuum and recrystallized from ethanol. The physical properties of synthesized compounds IIa-c mentioned in table 1 and spectral data in table 2.
Synthesis of 3-(4-substituted-phenyl)-2-(methylthio) quinazolin-4(3H)-one (IIIa-c): The compound (IIa-c) (0.02mol) was dissolved in 80 mL of 3% alcoholic sodium hydroxide solution. To this dimethyl sulphate (0.02 mol) was added drop wise with stirring. The stirring was continued for 1 h, the reaction mixture was then poured into ice water. The solid obtained of compound (IIIa-c) was filtered, washed with water, dried under high vacuum and recrystallized from ethanol chloroform (75:25) mixture. The physical properties of synthesized compounds IIIa-c mentioned in table 1 and spectral data in table 2.
Synthesis of 3-(4-substituted-phenyl)-2-hydrazinyl quinazolin-4(3H)-one (IVa-c): The compound (IIIa-c) (0.01 mol) was dissolved in ethanol (25 ml). To this hydrazine hydrate (99%) (0.1 mol) and anhydrous potassium carbonate (100 mg) was added and refluxed for 30 h. The reaction mixture was cooled and poured into ice water. The solid so obtained of compound (IVa-c) was filtered, washed with water, dried under high vacuum and recrystallized from chloroform benzene (25:75) mixture. The physical properties of synthesized compounds IVa-c mentioned in table 1 and spectral data in table 2.
TABLE 1: PHYSICOCHEMICAL DATA OF SYNTHESIZED COMPOUNDS
Compound code | R | Molecular formula | M Wt* | %yield | M.P. (0 c) | Color |
IIa | Cl | C14 H9ClN2OS | 288 | 80% | 306-308 | White |
IIb | Br | C14 H9BrN2OS | 333 | 72% | 300-302 | White |
IIc | NO2 | C14 H9N3O3 S | 299 | 70% | 154-156 | Yellow |
IIIa | Cl | C15 H11ClN2OS | 303 | 82% | 176-178 | White |
IIIb | Br | C15 H11BrN2OS | 346 | 85% | 129-131 | White |
IIIc | NO2 | C15H11N3O3 S | 313 | 65% | 166-168 | Yellow |
IVa | Cl | C14 H11N4OCl | 286 | 78% | 192-194 | White |
IVb | Br | C14 H11N4OBr | 330 | 75% | 166-168 | White |
IVc | NO2 | C14 H11N5O3 | 297 | 57% | 170-172 | Yellow |
* Molecular weight determinate by mass spectra
TABLE 2: SPECTRAL DATA OF SYNTHESIZED COMPOUNDS
Compound
code |
IR (cm-1) (KBr) | 1H NMR (CDCl3) δ ppm | ||||
NH | C=O | C=S | CH-Ar | CH-Ali | ||
IIa | 3248# | 1687 | 1200 | 3069 | - | 3.9629(s, 1H, -NH), 6.99-7.972(m, 8H, Ar-H) |
IIb | 3263# | 1694 | 1234 | 3078 | - | 3.9721(s, 1H, -NH), 7.013-8.786(m, 8H, Ar-H) |
IIc | 3449# | 1629 | 1258 | 3024 | - | 3.786(s, 1H, -NH), 7.113-8.77(m, 8H, Ar-H) |
IIIa | - | 1682 | - | 3064 | 2932 | 2.530(s, 3H, SCH3), 7.842-8.09(m, 8H, Ar-H) |
IIIb | - | 1675 | - | 3065 | 2956 | 2.528(s, 3H, SCH3), 7.426-8.094(m, 8H, Ar-H) |
IIIc | - | 1624 | - | 3063 | 2951 | 2.493(s, 3H, -SCH3), 7.421-8.102(m, 8H, Ar-H) |
IVa | 3324#*,3219# | 1677 | - | 3062 | - | 5.162-2.211(s, 2H, NH2), 7.227-8.024(m, 8H, Ar-H), 8.969-9.091(s, 1H, -NH) |
IVb | 3331#*,3215# | 1676 | - | 3089 | - | 5.189-5.231(s, 2H, NH2), 7.235-7.822(m, 8H, Ar-H), 9.013-9.278(s, 1H, -NH) |
IVc | 3321#*,3227# | 1641 | - | 2962 | - | 5.211-5.213(s, 2H, NH2), 7.351-7.788(m, 8H, Ar-H), 8.740-9.691(s, 1H, -NH) |
#* Primary amine stretching vibration frequency (cm-1); # Secondary amine stretching vibration frequency (cm-1)
Determination of Antimicrobial Activity: All the synthesized compounds were reported in table 1 were screened for their antibacterial and anti-fungal activity in vitro against gram positive bacteria ( Bacillus subtilis, Staphyllococcus aureus), gram negative bacteria (Escherichia coli) and fungi (Aspergillus niger, Candida albicans) using disc diffusion technique 10-14 at 100ug/ml concentration. The activity was compared with known standard streptomycin for antibacterial and fluconazole for antifungal activity. Dimethylformamide (DMF) was taken as solvent for all synthesized compounds. In order to account for the effect due DMF a blank was also performed.
Observations of anti-microbial study are mentioned in table 3.
RESULT AND DISCUSSION: The structures of the all synthesized compounds (IIa-c-IVa-c) were elucidated on the basis of, IR, 1H-NMR and mass spectroscopy. All the final synthesized compounds have strong absorption band around 1694-1624 cm-1, which is evidence for the presence of >C=O bond in all synthesized compounds. Presence of aromatic ring was confirmed by absorption band around 3078-2962 cm-1. IR data of all final synthesized compounds confirms the presence of specific functional groups present in the synthesized compounds. The mass and 1H-NMR spectra of were in conformity with assigned structures.
As per usual of the table 3, the antimicrobial activity of synthesized compounds as compared to standard drugs, all the synthesized compounds possessed anti-bacterial activity against all the five strains. Compound IIa, IIb and IIIa showed moderate activity against B. subtilis, E. coli and A. niger as compared to standard drug. Compound IIIb and Iva exhibited good activity against A. niger. Compound IIIc and IVc was found to be most active compound against E. coli and moderately active against B. subtilis and A. niger, of the prepared series.
ACKNOWLEDGEMENT:I am very thankful to University Grant commission, India for provide me financial support during my project work.
REFERENCES:
- Alagarsamy, V.; Solomon, V. Raja; Murugan, M.; Sankaranarayanan, R.; Periyasamy, P.; Deepa, R2008. Synthesis of 3-(2-pyridyl)-2-substituted-quinazolin-4(3H)-ones as new analgesic and anti-inflammatory agents: Pharmacother., 62: 454-461.
- Pandey, Sarvesh Kumar; Singh, Abhishek; Singh, Ashutosh; Nizamuddin,: 2009 Antimicrobial studies of some novel quinazolinones fused with [1,2,4]-triazole, [1,2,4]-triazine and [1,2,4,5]-tetrazine rings. J. Med. Chem., 44: 1188-1197.
- Joshi, Advait A.; Narkhede, Sachin S.; Viswanathan, C.L. 2005. Design, synthesis and evaluation of 5-substituted amino-2,4-diamino-8-chloropyrimido-[4,5-b]quinolines as novel antimalarials: Med. Chem. Lett., 15: 73-76.
- Jatav, Varsha; Mishra, Pradeep; Kashaw, Sushil; Stables, J.P. 2008. Synthesis and CNS depressant activity of some novel 3-[5-substituted 1, 3, 4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones. J. Med. Chem., 43(1): 135-141.
- Alagarsamy, V.; Shankar, D.; Murugesan, S. 2008. Synthesis of 4-butyl-1-substituted-4H-[1, 2, 4]triazolo[4,3-a]quinazolin-5-ones as new class of H1-antihistaminic agents. Pharmacother., 62(3): 173-178.
- Pandey VK, Kumar J, Saxena SK, Mukesh, Joshi MN, Bjpai SK, 2007. Synthesis and characterization and antiviral activity of 2,3-disubstituted quinazolones. J. Indian Chem. Soc., 84:593-597.
- Cao, Sheng-Li; Feng, Yu-Ping; Jiang, Yu-Yang; Liu, Shi-Ying; Ding, Guo-Yu; Li, Run-Tao, 2005. Synthesis and in vitro antitumor activity of 4(3H)-quinazolinone derivatives with dithiocarbamate side chains. Med. Chem. Lett., 15(7): 1915-1917.
- Jiri K, Jaroslav B, Milan P, Karel W, Milan S, Jiri J, 2000. Quinazoline derivatives with antitubercular activity. IL Farmaco, 55:725-729.
- Alagarsamy V, Raja Solomon, V.;,Dhanabal, K, 2007. Synthesis and pharmacological evaluation of some 3-phenyl-2-substituted-3H-quinazolin-4-one as analgesic, anti-inflammatory agents. Med. Chem., 15(1): 235-241.
- Pharmacopoeia of India, 1985. Ministry of health and family welfare, Government of India, Delhi, 3(2):85.
- Gupta V, Kashaw SK, Jatav V, Mishra P., 2008. Synthesis and antimicrobial activity of some new 3-[5-(4-substituted)phenyl-1,3,4-oxadiazole-2yl]-2-styrylquinazoline-4(3H)-ones. Med. Chem. Res., 17:205-211.
- M. Atlas, L.C. Parks, A.E. Brown. Laboratory manual of experimental microbiology, Mosby year book, Inc USA, 1995, 335.
- Daniel, Microbiology, WCB Mc-Graw Hill, Boston, 1998, 133.
- Microbial type culture collection and gene bank (MTCC) Catalogue, Institute of Microbial Technology, Chandigarh, 1998, 130.
How to cite this article:
Singh O, Namdeo KP and Sindhia VR: Synthesis of Quinazolinone Derivatives and their Antimicrobial Evaluation. Int J Pharm Sci Res. 3(11); 4408-4411.
Article Information
52
4408-4411
449KB
1011
English
Ijpsr
Ompal Singh *, K.P. Namdeo and V.R. Sindhia
Kharvel Subharti College of Pharmacy, Swami Vivekanand Subhari Universitry, Meerut 250004, Uttar Pradesh, India
ompalsingh72@gmail.com
23 July, 2012
28 August, 2012
29 October, 2012
http://dx.doi.org/10.13040/IJPSR.0975-8232.3(11).4408-11
01 November,2012